AKBA: Akebia Therapeutics Inc

3.51 USD 0.12 (3.31%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

AKBA exchange rate has changed by -3.31% for today. During the day, the instrument was traded at a low of 3.47 and at a high of 3.64.

Follow Akebia Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

AKBA News

Zacks 16:00 Akebia Therapeutics (AKBA) Upgraded to Strong Buy: Here's What You Should Know
Zacks 13:40 Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?
Investing 15:02 Akebia at H.C. Wainwright: Strategic Insights on Kidney Care Products
Seeking Alpha 15:00 Core CPI In Focus With JPMorgan, Goldman, Netflix Set To Report Earnings
Investing 13:59 Akebia Ther stock hits 52-week high at 4.08 USD
Investing 11:35 Akebia Therapeutics expands stock incentive plan
Seeking Alpha 03:36 Akebia Therapeutics (AKBA): Stock At Fair Value Amid Robust Drug Adoption Into 2026
Seeking Alpha 21:26 Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside
Seeking Alpha 20:23 Akebia Therapeutics: Finally Showing Potential, But Wait For Q2 Earnings First (AKBA)
Investing 12:06 Akebia reports mixed results for anemia drug in global study
Investing 11:04 H.C. Wainwright assumes coverage on Akebia Therapeutics stock with buy rating
Investing 16:06 Akebia Ther stock soars to 52-week high, hits $3.31
Investing 20:52 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 12:28 Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025
Investing 13:48 Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025
Investing 20:02 Akebia Therapeutics at H.C. Wainwright Conference: Vafseo’s Strategic Launch
Investing 13:39 Akebia Therapeutics stock soars to 52-week high of $2.91
Seeking Alpha 13:19 Akebia's Valuation Looks Stretched Despite Auryxia’s Loss Of Exclusivity (NASDAQ:AKBA)
Benzinga 16:01 Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase - Benson Hill (NASDAQ:BHIL), Akebia Therapeutics (NASDAQ:AKBA)
Benzinga 12:18 JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Akebia Therapeutics (NASDAQ:AKBA), Enerflex (NYSE:EFXT)
Benzinga 12:34 Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Akebia Therapeutics (NASDAQ:AKBA), Arlo Technologies (NYSE:ARLO)
Seeking Alpha 14:21 Akebia Therapeutics, Inc. (AKBA) Q4 2024 Earnings Call Transcript
Seeking Alpha 10:43 Akebia: Still Bullish On Vafseo As Auryxia's Revenues Decline (NASDAQ:AKBA)

Daily Range

3.47 3.64

Year Range

1.07 4.08

Previous Close: 3.59
Open: 3.63

Bid: 3.51
Ask: 3.81

Low: 3.47
High: 3.64

Volume: 3.590 K

Daily Change: -3.31%
Month Change: -3.31%

6 Months Change: 63.26%
Year Change: 152.52%

30 July, Wednesday